RETRACTED: Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study

Autor: Dummer, Reinhard *, *, Queirolo, Paola *, Abajo Guijarro, Ana Maria, Hu, Youyou, Wang, Dao, de Azevedo, Sergio Jobim, Robert, Caroline, Ascierto, Paolo Antonio, Chiarion-Sileni, Vanna, Pronzato, Paolo, Spagnolo, Francesco, Mujika Eizmendi, Karmele, Liszkay, Gabriella, de la Cruz Merino, Luis, Tawbi, Hussein
Zdroj: In The Lancet Oncology September 2022 23(9):1145-1155
Databáze: ScienceDirect